<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05089097</url>
  </required_header>
  <id_info>
    <org_study_id>ASO.Cch.19.01</org_study_id>
    <nct_id>NCT05089097</nct_id>
  </id_info>
  <brief_title>Assessment of Postoperative Delirium With CAM ICU Score in Patients Treated With Serotoninergic Reuptake (SSRI) Inhibitors and Undergoing Intervention of Heart Surgery on Pump</brief_title>
  <acronym>DeCAMS-ON</acronym>
  <official_title>Assessment of Postoperative Delirium With CAM ICU Score in Patients Treated With Serotoninergic Reuptake (SSRI) Inhibitors and Undergoing Intervention of Heart Surgery on Pump</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to observe the presence of postoperative delirium in patients undergoing&#xD;
      elective cardiac surgery, without changing the pharmacological prescriptions of the enrolled&#xD;
      patients and the procedures carried out by normal clinical practice.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2020</start_date>
  <completion_date type="Actual">September 15, 2021</completion_date>
  <primary_completion_date type="Actual">June 4, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence/absence of postoperative delirium</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>presence / absence of postoperative delirium, assessed with CAM-ICU, from awakening and for the following 48 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation with ICU-Length of Stay</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>Correlation with ICU-Length of Stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation with Hospital-Length of Stay</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>correlation with Hospital-Length of Stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>measure of bleeding in ml / day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>re-operated patient</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>Number of re-operated patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mechanical ventilation in intensive care</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>number of patients who required mechanical ventilation in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>mortality at 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infections</measure>
    <time_frame>4 june 2020 to 4 june 2021</time_frame>
    <description>number and type of infections that occurred following the operation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">152</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Inhibitors of serotoninergic reuptake on</arm_group_label>
    <description>patients with a diagnosis of depressive syndrome requiring treatment with Inhibitors of serotoninergic reuptake drugs excluding neurodegenerative diseases and on treatment with antidepressants for more than three months.&#xD;
Intervention: evaluation of the presence of postoperative delirium with the CAM-ICU score upon awakening and for the following 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhibitors of serotoninergic reuptake off</arm_group_label>
    <description>patients without a diagnosis of depressive syndrome requiring treatment with Inhibitors of serotoninergic reuptake drugs excluding neurodegenerative diseases and not in treatment with antidepressants.&#xD;
Intervention: evaluation of the presence of postoperative delirium with the CAM-ICU score upon awakening and for the following 48 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>evaluation of delirium with CAM-ICU Score</intervention_name>
    <description>the CAM-ICU score is an evaluation tool to verify the presence or absence of delirium in a subject</description>
    <arm_group_label>Inhibitors of serotoninergic reuptake off</arm_group_label>
    <arm_group_label>Inhibitors of serotoninergic reuptake on</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients over 18 years of age, of both sexes, undergoing elective cardiac surgery and with&#xD;
        the presence or absence of depressive pathology in therapy with Inhibitors of&#xD;
        serotoninergic reuptake&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inhibitors of serotoninergic reuptake on&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  patients over 18 years old&#xD;
&#xD;
          -  patients undergoing elective cardiac surgery&#xD;
&#xD;
          -  patients diagnosed with depressive syndrome requiring treatment with Inhibitors of&#xD;
             serotoninergic reuptake excluding neurodegenerative diseases&#xD;
&#xD;
          -  patients on antidepressant therapy for more than 3 months at the time of enrollment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  absence of written informed consent to the study&#xD;
&#xD;
          -  patients undergoing non-elective and emergency cardiac surgery&#xD;
&#xD;
          -  patients undergoing off pump surgery&#xD;
&#xD;
          -  patients with depression not on therapy&#xD;
&#xD;
          -  patients with existing malignancies&#xD;
&#xD;
          -  patients with acute infections in progress&#xD;
&#xD;
          -  patients with previous stroke, cerebral haemorrhage with relics&#xD;
&#xD;
          -  patients with acquired and congenital metabolic pathologies with CNS alterations&#xD;
&#xD;
          -  Patients with acute and / or chronic renal failure according to RIFLE score (exclude&#xD;
             only F-L-E)&#xD;
&#xD;
          -  Patients with acute and / or chronic hepatic insufficiency according to Child - Pugh&#xD;
             score &lt;6 (but without encephalopathy);&#xD;
&#xD;
          -  Patients with neurodegenerative diseases (dementias of all types both organic and&#xD;
             vascular, parkinson's and ongoing delirium);&#xD;
&#xD;
          -  Patients with previous or current drug and / or alcohol abuse&#xD;
&#xD;
          -  pregnant or postpartum period patients (6 months after delivery)&#xD;
&#xD;
        Inhibitors of serotoninergic reuptake off&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  patients over 18 years old&#xD;
&#xD;
          -  patients undergoing elective cardiac surgery&#xD;
&#xD;
          -  patients without a diagnosis of depressive and psychiatric illness requiring treatment&#xD;
             with psychoactive drugs to the exclusion of neurodegenerative diseases&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  absence of written informed consent to the study&#xD;
&#xD;
          -  patients undergoing non-elective and emergency cardiac surgery&#xD;
&#xD;
          -  patients undergoing off pump surgery&#xD;
&#xD;
          -  patients with depression not on therapy&#xD;
&#xD;
          -  patients with existing malignancies&#xD;
&#xD;
          -  patients with acute infections in progress&#xD;
&#xD;
          -  patients with previous stroke, cerebral haemorrhage with relics&#xD;
&#xD;
          -  patients with acquired and congenital metabolic pathologies with CNS alterations&#xD;
&#xD;
          -  Patients with acute and / or chronic renal failure according to RIFLE score (exclude&#xD;
             only F-L-E)&#xD;
&#xD;
          -  Patients with acute and / or chronic hepatic insufficiency according to Child - Pugh&#xD;
             score &lt;6 (but without encephalopathy);&#xD;
&#xD;
          -  Patients with neurodegenerative diseases (dementias of all types both organic and&#xD;
             vascular, parkinson's and ongoing delirium);&#xD;
&#xD;
          -  Patients with previous or current drug and / or alcohol abuse&#xD;
&#xD;
          -  pregnant or postpartum period patients (6 months after delivery)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo</name>
      <address>
        <city>Alessandria</city>
        <zip>15121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 11, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Delirium</keyword>
  <keyword>Postoperative</keyword>
  <keyword>CAM-ICU Score</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

